Transitioning from cigarettes to electronic cigarettes (e-cigarettes) is associated with resolution of respiratory symptoms, but the rate of resolution is reduced among those who switch to dual use or ...

The prevalence of any alcohol use and heavy alcohol use was higher in 2020 and 2022 compared with 2018. HealthDay News — The prevalence of any alcohol use and heavy alcohol use was higher in 2020 and ...

Virtual yoga classes may be a feasible, safe, and effective treatment option for chronic low back pain (CLBP). HealthDay News — Virtual yoga classes may be a feasible, safe, and effective treatment ...

HealthDay News — Asthma is associated with memory difficulties in children, according to a study published online Nov. 11 in JAMA Network Open.

Treatment with IV secukinumab led to rapid improvements in the signs and symptoms of PsA, which were maintained through 52 weeks.

For patients undergoing primary total hip replacement (THR), the rate of revision varies by type of material used in the bearing surface. HealthDay News — For patients undergoing primary total hip ...

Ciprofol, a novel propofol analogue, was favored over propofol in inducing anesthesia for colonoscopy as it resulted in lower injection pain and blood pressure reduction. In patients undergoing ...

Researchers found in-person and self-paced online Emotional Freedom Technique programs to be a potentially effective in the management of chronic pain in adults. Intervention programs that incorporate ...

Meteorological factors accounted for less than 1% of the variation in patient-reported outcomes among individuals with psoriatic arthritis. Meteorological factors may account for less than 1% of the ...

At-risk individuals who progress to rheumatoid arthritis (RA) have a distinctive gut microbial composition. HealthDay News — At-risk individuals who progress to rheumatoid arthritis (RA) have a ...

HealthDay News — COVID-19 is associated with long-term risk for autoimmune and autoinflammatory connective tissue disorders, according to a study published online Nov. 6 in JAMA Dermatology.

Calcium levels decreased less with each subsequent denosumab dose among individuals with osteoporosis and advanced chronic kidney disease.